Boston, MA -- (SBWIRE) -- 09/05/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (PDL BioPharma Inc. (NASDAQ:PDLI), Select Medical Holdings Corporation (NYSE:SEM), Affymetrix, Inc.(NASDAQ:AFFX), Cirrus Logic, Inc.(NASDAQ:CRUS)
PDL BioPharma Inc. (NASDAQ:PDLI) stock gained 2.72% to $7.93. The company on Sept. 4 announced that the adjusted conversion rate for the 3.75% Convertible Senior Notes due May 1, 2015 (May 2015 Notes), is 157.3700 shares of common stock per $1,000 principal amount or approximately $6.35 per share, effective September 3, 2013; and 2.875% Series 2012 Convertible Senior Notes due February 15, 2015 (Series 2012 Notes), is 179.777 shares of common stock per $1,000 principal amount or approximately $5.56 per share, effective September 3, 2013.
How Should Investors Trade PDLI After The Recent Volatility? Get Free Report Here
Select Medical Holdings Corporation (NYSE:SEM) shares dropped 3.19% and closed at $3.19 in the last trading session. The company on August 8 announced results for its second quarter ended June 30, 2013 and quarterly cash dividend.
For the second quarter ended June 30, 2013, net operating revenues increased 0.9% to $756.7 million compared to $750.2 million for the same quarter, prior year. Income from operations decreased 5.6% to $88.3 million compared to $93.5 million for the same quarter, prior year. Net income attributable to Select Medical decreased to $27.8 million compared to $43.2 million for the same quarter, prior year.
How Should Investors Trade SEM After The Recent Volatility? Get Free Report Here
Affymetrix, Inc.(NASDAQ:AFFX) shares increased 8.44% to $6.17. The company on August 5 announced the launch of the new OncoScan? FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor samples, at the Cancer Cytogenomics Microarray Consortium conference being held in Chicago.
Additionally, the company on July 31 reported its operating results for the second quarter of 2013. Product revenue for the second quarter of 2013 was $74.2 million and service and other revenue was $5.3 million. For the second quarter of 2013, operating expenses were $45.1 million on a GAAP basis as compared to $54.1 million in 2012.
Is AFFX A Good Buy After The Recent Price Movement? Find Out Here
Cirrus Logic, Inc.(NASDAQ:CRUS) shares gained 6.39% to $23.81. The company on July 25 reported first-quarter profit of $20.64 million or $0.31 per share, up from $6.93 million or $0.10 per share in the same period last year. Revenues totaled $155.13 million, up from $99.01 million last year. Analysts expected revenues of $160.12 million.
Looking forward, the company has forecast second quarter revenues in the range of $170 million to $190 million. Analysts currently expect second-quarter revenues of $189.99 million.
Is CRUS A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)